Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Deficiency of Adenosine Deaminase 2 (DADA2) Presenting As Familial Hodgkin Lymphoma

Fahad Alabbas, Omar Alsharief, Isabelle Meyts, Fatma Albatniji, Michael Hershfield, Adnan Mansoor, MD PhD, Ghaleb Elyamany, MD PhD

Blood (2018) 132 (Supplement 1): 5373.

https://doi.org/10.1182/blood-2018-99-116431

Published: 2018

Journal Articles

Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2

Blood (2017) 130 (24): 2682–2688.

https://doi.org/10.1182/blood-2017-07-798660

Published: 2017

Journal Articles

Diamond-Blackfan Anemia Phenotype Caused By Deficiency of Adenosine Deaminase 2

Blood (2017) 130 (Supplement 1): 874.

https://doi.org/10.1182/blood.V130.Suppl_1.874.874

Published: 2017

Journal Articles

Adenosine Deaminase 2 Deficiency As a Cause of Pure Red Cell Aplasia Mimicking Diamond Blackfan Anemia

Ghadir S. Sasa, MD, M. Tarek Elghetany, MD, Katie Bergstrom, Sarah Nicholas, MD, Ryan Himes, MD, Robert A. Krance, MD, Michael Hershfield, MD PhD, Joris van Montfrans, MD PhD, Alison Bertuch, MD PhD

Blood (2015) 126 (23): 3615.

https://doi.org/10.1182/blood.V126.23.3615.3615

Published: 2015

Journal Articles

Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients

Barbara Cassani, Massimiliano Mirolo, Federica Cattaneo, Ulrike Benninghoff, Michael Hershfield, Filippo Carlucci, Antonella Tabucchi, Claudio Bordignon, Maria Grazia Roncarolo, Alessandro Aiuti

Blood (2008) 111 (8): 4209–4219.

https://doi.org/10.1182/blood-2007-05-092429

Published: 2008

Includes: Supplemental data

Journal Articles

Comparative Results of Gene Therapy for Adenosine Deaminase Deficiency with or without PEG-ADA Withdrawal and Myelosuppressive Chemotherapy.

Robert Sokolic, MD, Greg Podsakoff, MD, Linda Muul, PhD, Barbara Engel, MD, Jayashree Jagadeesh, BS, Elizabeth Garabedian, RN, MSLS, Denise Carbonaro, Laura Tuschong, BS, Joanna Ireland, Michael Hershfield, MD, John Tisdale, MD, Cynthia Dunbar, MD, Alan Wayne, MD, Donald Kohn, MD, Fabio Candotti, MD

Blood (2007) 110 (11): 501.

https://doi.org/10.1182/blood.V110.11.501.501

Published: 2007

NARROW

Deficiency of Adenosine Deaminase 2 (DADA2) Presenting As Familial Hodgkin Lymphoma

Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2

Diamond-Blackfan Anemia Phenotype Caused By Deficiency of Adenosine Deaminase 2

Adenosine Deaminase 2 Deficiency As a Cause of Pure Red Cell Aplasia Mimicking Diamond Blackfan Anemia

Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients

Comparative Results of Gene Therapy for Adenosine Deaminase Deficiency with or without PEG-ADA Withdrawal and Myelosuppressive Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Deficiency of Adenosine Deaminase 2 (DADA2) Presenting As Familial Hodgkin Lymphoma

Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2

Diamond-Blackfan Anemia Phenotype Caused By Deficiency of Adenosine Deaminase 2

Adenosine Deaminase 2 Deficiency As a Cause of Pure Red Cell Aplasia Mimicking Diamond Blackfan Anemia

Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients

Comparative Results of Gene Therapy for Adenosine Deaminase Deficiency with or without PEG-ADA Withdrawal and Myelosuppressive Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only